Table 2.
Results for paired survey questions asked before and after HPV vaccine curriculum (N = 101).b
| Question | Mean Change in Likert response (95% CI)c |
p-valuea |
|---|---|---|
| Please rate your level of awareness of the benefits of the HPV Vaccine | +0.82 (0.66, 0.97) | <0.01 |
| Please rate how strongly you would recommend the HPV Vaccine to a female patient during a physical | +0.46 (0.33, 0.59) | <0.01 |
| Please rate how strongly you would recommend the HPV Vaccine to a female patient during a other visit | +0.84 (0.67, 1.01) | <0.01 |
| Please rate how strongly you would recommend the HPV Vaccine to a male patient during a physical | +0.96 (0.77, 1.15) | <0.01 |
| Please rate how strongly you would recommend the HPV Vaccine to a male patient during a other visit | +1.21 (1.01, 1.41) | <0.01 |
| Providers should recommend the HPV Vaccine to all eligible patients in their practice | +0.35 (0.23, 0.48) | < 0.01 |
| I would recommend the HPV Vaccine to eligible 9–10 year olds with vaccine hesitant parents | +0.81 (0.61, 1.01) | <0.01 |
| I would recommend the HPV Vaccine to eligible 11–17 year olds with vaccine hesitant parents | +0.41 (0.27, 0.55) | <0.01 |
| I would recommend the HPV Vaccine to eligible 17–26 year olds with vaccine hesitant parents | +0.32 (0.20, 0.43) | <0.01 |
| Please rate your comfort level conversing with HPV vaccine hesitant parents/patients | +1.37 (1.20, 1.54) | <0.01 |
| Please rate your comfort level educating patients and families who are hesitant about other medical decision (test, treatments, etc.) | +1.20 (1.04, 1.36) | <0.01 |
a
P-value is for paired t-test comparing pre- and post-intervention Likert responses for each survey question.
b
N varies by question and ranges between 98 and 101.
c
Mean change and 95% CI are for the difference in Likert responses between pre- and post-intervention.